Feed BPLPHARMA.BO
BP

Bharat Parenterals Limited BPLPHARMA.BO BSE · Healthcare · India

₹2,408.00 +9.16% +₹202.05

Summary

35 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 17% a year over the last 3 years.

What to watch

  • Operating profit does not even cover the interest on its debt.
  • Out of every 100 INR of revenue, only 0.3 INR is left as net profit.
  • It passes only 3 of the 9 points of the Piotroski financial health test.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
P/E today 1,227.6 5,480% higher
5-year average P/E 22.0
P/E today 1,227.6
Medical - Pharmaceuticals industry median

Today you pay 1,227.6 INR for 1 INR of yearly profit. Over the last five years it was 22.0 INR on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (INR)

Diluted EPS (INR)

Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 17% a year.

Growth in detail

Does it make money?

Poorly

Where 100 INR of revenue goes

Net profit, industry median (Medical - Pharmaceuticals) 6.1 INR

Out of every 100 INR of revenue, 0.3 INR is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Small, at risk
Yield
0.05%
Paid out of profit
55%

You receive ₹1.00 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy